Compositions of PD-1 antagonists and methods of use
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 29, 2014
Issued Date -
N/A
app pub date -
Dec 20, 2011
filing date -
Aug 25, 2008
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Methods of treating cancer and infectious diseases utilizing a treatment regimen comprising administering a compound that reduces inhibitory signal transduction in T cells, in combination with a potentiating agent, such as cyclophosphamide, to produce potent T cell mediated responses, are described. Compositions comprising the PD-1 antagonists and potentiating agents useful in the methods of the invention are also disclosed.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully